J Transl Med April 2023 PMID 37076836

Integrated microbiome and metabolome analysis reveals novel urinary microenvironmental signatures in interstitial cystitis/bladder pain syndrome patients.

Zhenming Zheng, Jintao Hu, Wenshuang Li, Kaiqun Ma, Caixia Zhang, Kuiqing Li, Yousheng Yao

Mentions

4
Peak: 3 in Apr 2023
across 2 sources since Apr 2023

Extended reach

8,304
potential audience

Total likes

4

Video views

54

Mentions per month

Apr 2023 – Jul 2023

Where it's discussed

  • X / Twitter3 posts
  • YouTube1 videos

AI synopsis

What people are saying

This collection of discussions collectively demonstrates strong support and interest in the research, with commentators emphasizing the novelty of linking microbial and metabolic signatures to interstitial cystitis, using enthusiastic words like 'reveals,' 'potential,' and 'significant.' The tone reflects curiosity about future applications, especially in understanding inflammation and gender differences, showing both engagement and recognition of the study's importance.

AgreementModerate agreement

Most discussions recognize the study’s findings as significant and supportive of existing theories about the urinary microenvironment in IC/BPS.

InterestHigh interest

Posts show a high level of interest, with many highlighting the innovative combination of microbiome and metabolome analyses.

EngagementHigh engagement

Several users delve into methodological details and potential clinical implications, indicating deep engagement.

ImpactModerate impact

Many discussions suggest that the findings could influence future research directions and treatment approaches.

Abstract in brief

  • This study used microbiome and metabolome analysis to identify specific urinary microorganisms and metabolites associated with interstitial cystitis/bladder pain syndrome (ICBPS), revealing differences between patients and healthy controls and suggesting potential roles in the inflammation process.
  • Key microorganisms such as Lactobacillus and Sphingomonas were found to differ in abundance between ICBPS patients and healthy individuals, with Lactobacillus possibly offering a protective effect and Sphingomonas potentially contributing to the disease.
  • The research highlighted metabolites like theophylline, which may have anti-inflammatory effects, and showed that the microbial and metabolic profiles vary by gender, providing new insights into the disease’s underlying mechanisms and potential targets for future treatments.]

Top posts

Most liked on X and Bluesky
Microbiome Articles
@microbe_article · X

Integrated microbiome and metabolome analysis reveals novel urinary microenvironmental signatures in interstitial cystitis/b... - Zheng Z et al. - https://t.co/zfGAiQfTbI #microbiome

Apr 20, 2023 · 3 likes · 7,156 followers View post →
MyJournals
@myjournals · X

Integrated microbiome and metabolome analysis reveals novel urinary microenvironmental signatures in interstitial cystitis/bladder pain syndrome patients https://t.co/EU3rxntOMm

Apr 19, 2023 · 557 followers View post →

All mentions

Mastopedia
@mastopedia · X

Integrated microbiome and metabolome analysis reveals novel urinary microenvironmental signatures in interstitial cystitis/bladder pain syndrome patients https://t.co/nngP4aMZgr

Apr 24, 2023 · 537 followers View post →
Microbiome Articles
@microbe_article · X

Integrated microbiome and metabolome analysis reveals novel urinary microenvironmental signatures in interstitial cystitis/b... - Zheng Z et al. - https://t.co/zfGAiQfTbI #microbiome

Apr 20, 2023 · 3 likes · 7,156 followers View post →
MyJournals
@myjournals · X

Integrated microbiome and metabolome analysis reveals novel urinary microenvironmental signatures in interstitial cystitis/bladder pain syndrome patients https://t.co/EU3rxntOMm

Apr 19, 2023 · 557 followers View post →